Business, energy, technology, markets and global industry news from Business News Today

diabetes drugs

Pharma & Biotech

Can Apotex crack the complex generic code for semaglutide before the glucagon-like peptide-1 market resets?

Apotex won first tentative U.S. approval for generic semaglutide. Read what it could mean for glucagon-like peptide-1 access, pricing, and competition.

Read More